How could employing the patient perspective transform pharmacovigilance?

van den Bemt, P M L A; van Puijenbroek, E P; van Hunsel, F P A M

van den Bemt, P M L A; van Puijenbroek, E P; van Hunsel, F P A M.

Affiliation

van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, The Netherlands.
van Puijenbroek EP; Science and Engineering, University of Groningen, Groningen, The Netherlands.
van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands.

Expert Opin Drug Saf ; 23(7): 793-796, 2024 Jul.

Article in En | MEDLINE | ID: mdl-38922349

Subject(s)

Drug-Related Side Effects and Adverse Reactions; Pharmacovigilance; Humans; Drug-Related Side Effects and Adverse Reactions/epidemiology; Adverse Drug Reaction Reporting Systems; Patient Participation

Key words

Patient involvement; adverse drug reactions; pharmacovigilance; voluntary reporting

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / Pharmacovigilance Limits: Humans Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google